E
Xilio Therapeutics, Inc. XLO
$0.7204 $0.01141.61%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 6.31M 6.90M 7.40M 8.17M 7.17M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 17.36M 20.12M 23.53M 23.17M 20.21M
Operating Income -17.36M -20.12M -23.53M -23.17M -20.21M
Income Before Tax -16.75M -19.36M -22.65M -22.47M -19.79M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -16.75M -19.36M -22.65M -22.47M -19.79M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -16.75M -19.36M -22.65M -22.47M -19.79M
EBIT -17.36M -20.12M -23.53M -23.17M -20.21M
EBITDA -16.90M -19.62M -23.03M -22.68M -19.73M
EPS Basic -0.61 -0.70 -0.83 -0.82 -0.72
Normalized Basic EPS -0.38 -0.44 -0.52 -0.51 -0.45
EPS Diluted -0.61 -0.70 -0.83 -0.82 -0.72
Normalized Diluted EPS -0.38 -0.44 -0.52 -0.51 -0.45
Average Basic Shares Outstanding 27.52M 27.47M 27.43M 27.42M 27.40M
Average Diluted Shares Outstanding 27.52M 27.47M 27.43M 27.42M 27.40M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings